Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > 👀Fud Before no sales &now there been essentially no sales😉
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by jopatcloon Nov 14, 2024 8:31am
38 Views
Post# 36312301

RE:RE:RE:RE:RE:👀Fud Before no sales &now there been essentially no sales😉

RE:RE:RE:RE:RE:👀Fud Before no sales &now there been essentially no sales😉Good news this morning Pandora the negative shows this to your great friend the vulture GranhamB. who has been mad at Ventripoint for years...probably a guy who was shown the door to Ventripoint :-) We at rock bottom now. A turn around and the 'climb' should be starting soon. Good time to get in.3..... 2.... 1.... 0.... Launch! $$$ Dr. Adams is a visionary with Ventripoint.I think they know more about the Ventripoint tech than the whiners on this board. Something could happen anytime real fast! FDA V4.0 and Sales at any time now . That V4.0 Europe V4.0 ok & Canada The BEST automation and analysis of the PLANET GEN3EHO  https://ascendcv.com/
 & CardioLogic Ltd Introducing Ventripoint 4.0! Ventripoint is a groundbreaking cardiac imaging tool that converts echo images into accurate volumes and ejection fractions for all four heart chambers, delivering results with the accuracy of cardiac MRI.$$$ #vpt,
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities